A trend of declining hospital admissions for alcohol-related liver disease during the 2010s abruptly stopped when the COVID-19 pandemic hit, Australian researchers say. The researchers…
Semaglutide may double the resolution rate of non-alcoholic fatty liver disease in patients with stage 2 or 3 fibrosis, a Novo Nordisk-funded study across 37…
When Australia missed its target of treating 20% of chronic hepatitis B patients in 2022, there was one exception. Even in 2023, the national treatment…
A 47-year-old man died from acute liver failure after less than four months on the maximum recommended dose of paracetamol, a coroner says. Paul McHugh,…
In recent years, the gut microbiome has emerged as a pivotal player in human health, with profound implications for various chronic illnesses within and outside…
Doctors can be reassured that apixaban is safe for patients with AF and liver disease, a retrospective cohort study suggests. The Harvard University-led study found…
Sera is a 35-year-old receptionist whose optometrist has recommended she see her GP regarding corneal lesions. Test your clinical know-how by taking the quiz below.…
Fluoroquinolones and third-generation cephalosporins should be first-line antibiotics for liver cyst infections and ‘preferably’ used for six weeks, new guidance says. An international panel of…
Mothers with a history of gestational diabetes have a 50% higher risk of subsequent non-alcoholic fatty liver disease, while the risk is more than doubled…
A little learning is a dangerous thing; Drink deep, or taste not the Pierian spring: × Welcome to AusDoc. Enabling and empowering the medical community…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
